INS and Insulin resistance: Although hepatic insulin resistance (i.e., HOMA‐IR) was unaltered after the intervention (−0.10 ± 1.0 a.u., p = 0.67), peripheral insulin sensitivity (i.e., SIis) increased (0.004 ± 0.006 a.u., p = 0.003, Table 1).